Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Burden of glucocorticoid use in commercially insured adults with generalized myasthenia gravis in the United States: A retrospective claims-based analysis.
Journal: Medicine
Published: November 05, 2025
Real-world clinical and economic burden of immunoglobulin-G4-related disease in the United States: A retrospective claims-based analysis.
Journal: Medicine
Published: June 16, 2025
Burden of Glucocorticoid Use and Risk of Toxicities Among Patients with Immunoglobulin-G4-Related Disease: A Retrospective US-Based Claims Study.
Journal: Rheumatology and therapy
Published: January 13, 2025
B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity.
Journal: Annals of clinical and translational neurology
Published: December 21, 2023
Case report: Transition from anti-CD20 therapy to inebilizumab for 14 cases of neuromyelitis optica spectrum disorder.
Journal: Frontiers in neurology
Published: December 08, 2023
Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
Journal: Annals of clinical and translational neurology
Published: July 12, 2023
Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 07, 2023
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 12, 2023
Younger Age at Onset Is Associated With Worse Long-term Behavioral Outcomes in Anti-NMDA Receptor Encephalitis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: November 09, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.
Journal: Nature medicine
Published: June 22, 2021
TAPAS: A Thresholding Approach for Probability Map Automatic Segmentation in Multiple Sclerosis.
Journal: NeuroImage. Clinical
Published: August 12, 2019
Anti-MOG encephalitis mimicking small vessel CNS vasculitis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 16, 2018
Last Updated: 09/26/2026